Ozempic, a Type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines. The U.S. Food and Drug Administration ...
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers federal public health agencies. Ozempic now joins other products in this booming class of so-called GLP ...
(CNN) - The Food and Drug Administration updated the label of the diabetes drug Ozempic to acknowledge reports of blocked intestines in some people using it. Ozempic and its sister weight loss drug, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback